Background:DNA-alkyltransferases repair mutagenic and carcinogenic alkylation DNA lesions. Results:A thermophilic archaeal DNAalkyltransferase is degraded after alkylation in vivo. A novel assay is applied to study its activity in vitro.
while the gene transcription is induced by alkylating agent treatment, the protein is degraded in vivo by an alkylation-dependent mechanism. These experiments suggest a striking conservation, from archaea to humans, of this important pathway safeguarding genome stability. _______________________________________ DNA-alkyltransferases (called AGT, OGT or MGMT, E.C.: 2.1.1.63) are conserved proteins that catalyze repair of alkylation damage by a one-step mechanism involving the transfer of the alkylic group from O 6 -alkyl-guanine or O 4 -alkylthymine to a cysteine residue in their own active site (for recent reviews, see 1, 2). AGTs are called "suicide" or "kamikaze" proteins, since the stoichiometry of the reaction is 1:1 and the alkylated form of the protein is irreversibly inactivated (2, 3) . In human cells, alkylated AGT is rapidly directed to the degradation ubiquitin pathway, due to alkylationinduced conformational change that turns the protein into a proteolysis-sensitive form (4) .
Whereas AGT protects from mutagenic and carcinogenic effects of alkylating agents, in humans it also plays a role in the onset of resistance to alkylating agents used in the treatment of several cancer types (5) . Human AGT (hAGT) is strongly inhibited by O 6 benzylguanine (O 6 -BG), whose benzylic group is transferred to the active site cysteine (2) ; this inhibitor is already used in clinical trials to increase the effectiveness of alkylation-based chemotherapy. Moreover, AGT overexpression is a possible strategy to protect normal cells against the effects of chemotherapy (6) .
The resolution of the 3D structure of hAGT in complex with DNA revealed a unique mechanism for DNA recognition and repair (4, 7) . The protein contacts the DNA minor groove trough its helix-turn-helix domain; in order to access the alkyl group, which stands inside the double helix, the protein flips out the damaged base, while an arginine residue forms interactions with the orphaned base. Despite the reported studies, however, details of the interaction with DNA and lesion recognition are not completely understood; in particular, it remains to be established whether in order to find the lesion, the protein needs to flip out every base or it is able to recognize some structural feature of the damaged base simply scanning the double helix. AGTs are present in organisms from the three living domains (Eucarya, Bacteria, Archaea). For thermophilic organisms, alkylation lesions are particularly harmful, since at high temperature unrepaired alkylated bases can be easily converted into abasic sites or DNA breaks that in turn can cause DNA fragmentation. Indeed, we have previously reported that the alkylating agent methylmethanesulfonate (MMS) is highly cytotoxic for the archaeon Sulfolobus solfataricus, which grows optimally at 80 °C (8) . Limited information is available on thermophilic AGTs and their function and regulation. The 3D structure of AGT homologs from two thermophilic archaea, Methanococcus jannaschii (9) and Sulfolobus tokodaii (PDB entry 1WRJ) has been determined, revealing overall similarities with the human protein. The MGMT from the archaeon Pyrococcus sp. KOD1, overexpressed in E. coli, showed remarkable stability at high temperature and complemented the alkylating agents sensitive phenotype of an Escherichia coli ogt deficient strain (10, 11) . Other thermophilic AGTs were either not active (e.g., the AGT-like protein of Thermus thermophilus; 12) or poorly characterized because were not soluble when heterologously expressed (e.g., the AGTs from the bacterium Aquifex aeolicus and the archaeon Archaeoglobus fulgidus; 13).
We report here in vitro and in vivo studies on the DNAalkyltransferase from the hyperthermophilic archaeon S. solfataricus (SsOGT). The protein was over-expressed in recombinant form in Escherichia coli and characterized by using a novel method based on a fluorescent derivative of the competitive inhibitor O 6 -BG, showing that the protein is highly stable and active under a wide range of physical-chemical parameters. The assay also allowed the characterization of SsOGT mutant proteins with reduced or abolished DNA binding activity.
In S. solfataricus cells, the SsOGT RNA level was increased after exposure to MMS, confirming its involvement in repair of alkylation damage. Interestingly, the SsOGT protein was degraded in these cells in a MMSconcentration dependent fashion. We were able to demonstrate that degradation is a direct effect of the protein alkylation, and the degradation pathway is activated by MMS treatment. These experiments suggest a striking conservation, from archaea to humans, of the degradation mechanism that eliminates SsOGT after its action.
EXPERIMENTAL PROCEDURES
Reagents. Chemicals were purchased from Sigma (St Louis, MO, USA), E. coli strains and Pfu DNA polymerase were from Stratagene (La Jolla, CA, USA). Synthetic oligonucleotides were from Primm (Milan, Italy) and are listed in Supplementary Tab. I. DNA manipulation enzymes, as well as the SNAP-Vista Green™ substrate were from New England BioLabs (Ipswich, MA, USA). The pQE31™ vector was from Qiagen (Hilden, Germany).
DNA constructs. The Ssogt gene (ORF SSO2487) was amplified from S. solfataricus P2 genomic DNA (14) by using the oligonucleotides Ogt-5' and Ogt-3', which possess an internal BamHI and HindIII site, respectively (Supplementary Tab. I). These sites allowed the insertion of the BamHI/HindIII amplified fragment in the pQE31™ vector, in the same frame and downstream of a hexahistidine tag, leading to the pQE-ogt plasmid. The SsOGT protein expressed from this plasmid contains four extra aminoacid residues at its C-terminal ( 152 LQPG 155 ). The SsOGT R102A mutant was obtained in the pQE-ogt plasmid using the GeneTailor™ Site-Directed Mutagenesis System (Invitrogen, Carlsbad, CA, USA) with the following oligonucleotides: R102Amut and R102Arev (Supplementary Tab. I). The synthetic SsOGT-H 5 gene was custom-made by Geneart AG (Regensburg, Germany); it contains five point mutations (S100A, R102A, G105K, M106T, K110E) in the DNA binding region ( Supplementary Fig. 1A ), a mutation in position 132 (S132E), and a small multi-cloning site before the stop codon. The SsOGT-H 5 mutant protein contains six extra aminoacid residues at its C-terminal ( 152 LQVPST 157 ). Proteins. All proteins were expressed in the E. coli ABLE C strain. Cultures were grown at 37 °C in 1.0-2.0 L of Luria-Bertani (LB) medium supplemented with 50.0 µg/mL of ampicillin, and were induced for 16 h with 0.2-0.5 mM IPTG when an absorbance value of 0.8-1.0 O.D. 600nm was reached. Cells were centrifuged for 15 min at 6000 rpm in a Sorvall GSA rotor, resuspended 1:3 (w/v) in buffer A (phosphate 50 mM, NaCl 500 mM, pH 7.4), treated with lysozyme (1.0 mg/g wet cells) and Benzonase™ (Novagen, 25.0 U/g wet cells) for 1 h at room temperature, and finally lysed sequentially by a French Press and a sonicator, while kept refrigerated. The lysate was clarified by centrifugation for 30 min at 60000 × g in a Beckman 70 Ti rotor, and the cell free extract was applied to a HisTrap HP 1.0 mL FPLC column (GE Healthcare). After two washing steps of 10 CV of buffer A and 10 CV of buffer A supplemented with 0.1 M imidazole, the elution was performed in 20 CV of buffer A, by applying a linear gradient of 0.1-0. (Fig. 1A) . After annealing, the fragment was 3'-labeled with 32 P-αCTP using 5.0 U of Klenow fragment for 1 h at 37 °C. The mixture containing the labeled dsDNA was incubated with appropriate amounts of SsOGT at 70 °C for 10 min in OGT Reaction Buffer (Tris-HCl 50.0 mM, DTT 1.5 mM, EDTA 0.1 mM, glycerol 20 %, pH 8.0), the reaction was stopped on ice and incubated with 5.0 U of MboI supplemented with 10.0 mM MgCl 2 and 0.1 M NaCl for 1 h at 37 °C. Samples were denatured after addition of a Stop solution (95 % formamide, 20.0 mM EDTA, 0.05 % bromophenol blue) and run on 8 % sequencing gel. This was analyzed by autoradiography with a Storm PhosphoImager System (GE Healthcare).
Fluorescent assay for O 6 -alkyl-guanine alkyltransferase activity. In each sample, about 5.0 µM of protein (0.1 µg/µL) was incubated at 25 °C with 5.0 µM of the SNAP-Vista Green™ substrate in a total volume of 10.0 µL of Fluo Reaction Buffer 1X (phosphate 50.0 mM, NaCl 100 mM, DTT 1.0 mM, pH 6.5) for 20 min. Samples were denatured and loaded on 15% acrylamide SDS-PAGE; bands were visualized by direct gel imaging using the VersaDoc 4000™ system (Bio-Rad), applying a blue led/530 BP filter as excitation/emission parameters, respectively; the intensity of the bands was determined using the relative Quantity One™ software. Values were corrected for the actual amount of protein loaded in each lane, by measuring the intensity of bands after Coomassie staining, and final data were plotted by using the GraFit 5.0 software (15). The reaction conditions described above were conventionally indicated as standard; any changes from these conditions are indicated. Activity assay at different pH conditions was carried out in 50.0 mM sodium citrate (pH 3.0, 4.0, and 5.0), 50.0 mM sodium phosphate (pH 6.0, 6.5, and 7.0), 50.0 mM TrisHCl (pH 7.5 and 8.0), and 50.0 mM borate (9.0 and 10.0). For thermostability studies, 10 µL aliquots of reactions containing 5.0 µM of the protein in Fluo Reaction Buffer 1X, incubated at appropriate temperatures for different time spans, were centrifuged for 2 min at 16000 × g. Soluble fractions were then incubated in the presence of the substrate under standard conditions. Second-order rate constants of the labeling reactions were determined by incubation of purified SsOGT or SsOGT-H 5 mutant (5.0 µM) in the presence of an excess of SNAP-Vista Green™ (20.0 µM) in Fluo Reaction Buffer 1X at 25 and 70 °C, taking aliquots at different times. Final corrected data from gel imaging were used for the determination of constants as described (16) . 
Determination of kinetic parameters for the reaction of SsOGT and
intensity (FI) data were fitted by a linear equation, whose slope gave a direct reference value of FI/micromolar protein concentration, which was then used to estimate the amount of covalently modified protein (in pmol) in timecourse experiments. These were performed at 50 °C using different protein/SNAP-Vista Green™ molar ratios, taking 10.0 µL aliquots at specified intervals. Plots of the pmols of modified proteins versus time were fitted by exponential equations, for the determination of the apparent rates for covalent modification (k obs ). These values were plotted versus the SNAP-Vista Green™ doses (VG) using the hyperbolic equation 1, (1) where k and K VG are the rate of covalent linkage and the dissociation constant for the free enzyme and free substrate during the first collision step, before covalent modification, respectively. Real Time-PCR. Culture growth and MMS treatment, RNA extraction and cDNA preparation were performed as previously described (8) . Real Time PCR was performed by using the Ogt-left and Ogt-right oligonucleotides (Supplementary Tab. I); normalization was with the 16S rRNA (8) .
Cell-free extract preparation and analysis. Culture growth and MMS treatment was performed as previously described (8, 17) . Normalization was with either the anti-SSB (18) or the anti-β-subunit of prefoldin (8) antibody.
RESULTS
Identification of SsOGT and development of a new assay for its activity. The S. solfataricus ORF SSO2487 encodes a putative 151 aminoacids polypeptide homologous to DNA alkyltransferases, we called SsOGT, with a predicted molecular mass of 17.0 kDa. Aminoacid sequence alignment of SsOGT with hAGT and selected homologs from thermophilic archaea and bacteria showed conservation of sequence motives known to be involved in the protein activity ( Supplementary Fig. 1A ). Given the high (67.5 %) aminoacid sequence identity with the Sulfolobus tokodaii homolog, we used the crystal structure of the latter (PDB entry 1WRJ) to obtain a reliable 3D structure prediction for SsOGT. The model predicts high overall structural similarity between SsOGT and hAGT ( Supplementary Fig. 1B) .
A his-tagged version of SsOGT, overexpressed and purified from E. coli cultures, revealed a monomeric structure in solution, as determined by size exclusion chromatography (data not shown). In order to test SsOGT activity we first used a gel-based assay (3, 7) . We designed a dsDNA oligonucleotide substrate (ds-UP m ) containing a single O 6 -methylated guanine overlapping a restriction site for the methylation-sensitive MboI enzyme; removal of the methyl group by SsOGT would restore MboI cleavage assay (Fig. 1A) . SsOGT turned out to be a bona fide DNA-alkyltransferase (Fig. 1B) .
This assay was quite laborious and time consuming, as are all assays currently available to test DNA-alkyltransferase activity (3, 7, (19) (20) (21) . We thus set up an alternative, simpler and faster method to analyze OGT activity, based on fluorescent derivatives of O 6 -BG. This molecule is known to inhibit hAGT by covalent transfer of the benzylic group to the active site cysteine (2), and its fluorescent conjugates are currently used to label derivatives of hAGT (SNAP-tag™) (16, 22, 23) . We reasoned that, because of the irreversible nature and the 1:1 stoichiometry of the reaction, the amount of bound inhibitor could be used as a direct measure of the protein activity; in addition, thanks to the covalent protein-inhibitor bond, the complex could be analyzed even under denaturing conditions ( Fig.  2A) .
We first tested the SsOGT activity towards a fluorescein derivative of O 6 -BG (SNAP-Vista Green™) by incubation at 70 °C; activity was assessed by quantification of fluorescent protein band in SDS-PAGE. SNAP-Vista Green™ was bound covalently and the fluorescent band intensity showed a linear dependence on the inhibitor concentration (Fig. 2B) , reaching a plateau at 1:1 protein:inhibitor ratio, thus confirming the predicted stoichiometry and suicide nature of this reaction. Using this technique, as little as 10 ng of protein could be detected (data not shown). Time course experiments performed at different protein:fluorescent substrate/inhibitor ratios (Fig.  2C ) led to the determination of kinetic constants for the covalent modification of SsOGT by SNAP-Vista Green™ at 50 °C, which are listed in Tab. I.
In order to compare the affinity of SsOGT for the inhibitor versus a natural substrate, we performed competition assays by adding increasing amounts of ds-UP m or its nonmethylated counterpart (ds-UP; Supplementary Tab. I) to standard SsOGT labeling reactions (Fig. 2D) . In the presence of ds-UP m , strong reduction of the fluorescent labeling efficiency was observed, which dropped to about 90 % at 1.0:1.0 DNA:SNAP-Vista Green™ ratio. No competition was observed with ds-UP, even at high DNA:inhibitor ratio, suggesting that inhibition is due to the presence of the methylguanine group and not to non-specific binding to Supplementary Fig. 2B ), allowed the calculation of the affinity of SsOGT for ds-UP m (K DNA ), which was one order of magnitude lower than K VG (Tab. I), confirming data reported in Fig. 2D . Taken together, these experiments demonstrate that our assay can be used for the exact determination of the protein affinity for different natural as well as synthetic substrates and inhibitors.
Fluorescent labelling of SsOGT could be seen in intact E. coli cells incubated with SNAP-Vista Green™ (Fig. 3) , and gel imaging after SDS-PAGE of whole E. coli cells extracts expressing SsOGT revealed a single fluorescent band of the expected molecular weight (data not shown). From these experiments we conclude that fluorescent labelling is a sensitive and specific method for qualitative and quantitative analysis of SsOGT activity and we used it in all the subsequent experiments.
Biochemical characterization of SsOGT. In agreement with the thermophilic nature of its natural source, the SsOGT optimal activity was at 80 °C; however, significant activity was found at temperature as low as 25 °C (Fig. 4A) , a property quite unusual for thermophilic proteins, which generally show very low or no activity at low temperature. Second-order rate constants calculations of the reaction showed that at 70 °C the SsOGT reaction is very fast and is completed in a few minutes. The values obtained at this temperature (5.33 ± 1.49 x 10 4 s -1 M -1 ) were in the same order of magnitude of that measured at 24 °C for the modified hAGT SNAP-tag ™ (2.8 x 10 4 s -1 M -1 ) by using a similar substrate (16) . When the same experiment was performed at 25 °C, SsOGT was found ca. 20-fold less active (0.28 ± 0.03 x 10 4 s -1 M -1 ). SsOGT showed significant activity in the pH 5.0-8.0 interval, with an optimum at pH 6.0 (Fig.  4B) and was tolerant to a number of different reaction conditions (Fig. 4C) , such as ionic strength (0.0-1.0 M NaCl) and glycerol (up to 20 %); the protein was also resistant to low concentration of SDS and Triton X-100 (0.01 % and 0.1-0.5 %, respectively), while it was markedly more active in sarcosyl at all tested concentrations (0.1-1.0 %). Interestingly, the protein was insensitive to EDTA up to 10.0 mM, suggesting that, in contrast to hAGT, SsOGT does not contain any structural Zn 2+ ion. SsOGT activity showed high thermal stability (Supplementary Tab. II). Analysis of SsOGT mutants in DNA binding activity. Structural analysis has shown that in hAGT, DNA binding depends on residues forming a helix-turn-helix motif (HTH), which are involved in the direct interaction with the DNA minor groove (7); in particular, mutation of the arginine 128 residue was shown to reduce DNA binding (24) . Sequence alignment and structural prediction showed strong conservation of these residues among AGT homologs ( Supplementary Fig. 1A) . In order to test the involvement of these residues in DNA binding, we obtained the single mutant SsOGT-R102A (with R102 corresponding to R128 in hAGT) and a multiple mutant (SsOGT-H 5 ) carrying in addition to R102A, substitution of four conserved residues in the HTH domain (S100A, G105K, M106T, K110E). The mutant proteins were expressed and purified as described for the wild type. DNA binding assays performed with a TMR-labelled oligonucleotide (Supplementary Tab. I) showed that the wild type SsOGT binds dsDNA in a cooperative manner, as reported for hAGT (24) , with a plateau at a protein/DNA ratio of 15 (Fig. 5A) Supplementary Fig.  3 ). Kinetic analysis was performed as reported for the wild-type protein, with the exception that, in order to calculate the K VG , the reciprocal values of the experimental data were fitted by linearization of equation 1. This analysis showed reduced affinity of the mutant for SNAP-Vista Green™ as compared with the wild-type, with no reduction of the reaction rate, suggesting that the mutations affected, besides DNA, also the inhibitor binding. As reported in Tab. II, identical K VG values were obtained in the absence and in the presence of 1.25 µM ds-UP m , indicating that the presence of this substrate does not affect the labeling efficiency of SsOGT-H 5 , confirming data in Fig. 5B . These experiments suggest that our assay can also be applied to the characterization of proteins with impaired DNA binding. Using this assay, we found that the SsOGT-H 5 protein shows pH dependence and activity under different conditions not significantly different from the wild-type (Fig.  4B and C) . The temperature dependence was also similar to that of the wild type in the 25.0-80.0 °C range, while at 90.0 °C the activity of the H 5 mutant was reduced (Fig. 4A) , likely due to lower stability at this temperature, as also suggested by thermal stability analysis (Supplementary Tab. II). SsOGT in DNA damage response. Treatment of S. solfataricus cultures with > 0.25 < 0.7 mM of MMS induce transient growth arrest lasting up to 24 h, followed by growth resumption, suggesting efficient repair of alkylation damage; in contrast, MMS concentrations higher than 0.7 mM induce cell death, DNA fragmentation and degradation of proteins involved in DNA damage response and tolerance (Fig. 6A) (8, 25) .
Quantitative RT-PCR experiments showed that the SsOGT steady-state RNA level increases 1 h after addition of MMS in a drug concentration-dependent fashion (Fig. 6B) , thus confirming that the protein is involved in alkylation damage repair. An antibody raised against the recombinant SsOGT detected a single protein band of the expected molecular weight in total extracts as well soluble fractions prepared from exponentially growing S. solfataricus cultures (Fig. 6C) ; no protein band was detected in insoluble fractions (not shown). Surprisingly, despite the observed transcriptional induction, the intracellular SsOGT protein level was significantly reduced 2 h after treatment with 0.35 mM MMS and was almost absent if 1.4 mM MMS was used (Fig. 6C) , suggesting that the protein is degraded after the alkylating agent treatment. Since methylated AGT undergoes specific degradation in human cells (26) , we hypothesized that a similar mechanism may function in S. solfataricus. The analysis of SsOGT content in extracts from cells treated with different MMS conditions for different time spans showed different kinetics of SsOGT disappearance, depending on the drug concentration: 0.25 mM MMS induced slight reduction of the protein, detectable 6 h after treatment (Fig. 6D) ; at 0.35 mM, the protein level reduction was seen 2 h after addition of the drug, reached the minimum at 6 h (when the protein content dropped to about 1/5 of that found in untreated cells) and started increasing again after 24 h (Fig. 6D) ; finally, at 0.7 mM, SsOGT reduction was detectable 30 min. after MMS addition and was more marked after 2 h; no increase in the protein content was seen at later times (Fig. 6D and data not shown) . Thus, the protein content showed inverse correlation with MMS concentrations, which was consistent with alkylation-dependent degradation.
To test whether SsOGT degradation is dependent on its alkylation, we incubated normal or alkylated recombinant SsOGT with extracts from either controls or 0.35 mM MMS-treated cultures (Fig. 7A) . The same level of his-tagged SsOGT was observed when the protein was incubated with both extracts; however, if the protein had been previously alkylated in vitro by incubation with ds-UP m , its level was reduced in extracts from MMS-treated, but not control cultures. Thus, SsOGT alkylation triggers its degradation, but only in extracts from MMStreated cells. In addition, when extracts from control cells were incubated with either 1.0 mM MMS or the ds-UP m oligonucleotide, endogenous SsOGT was not degraded (Fig. 7B) , showing that not only the recombinant, but also the endogenous SsOGT is not degraded in extracts from untreated cells, regardless of its alkylation status. Taken together, these experiments suggest that SsOGT degradation depends on its alkylation and is a process activated in vivo in response to alkylation damage.
DISCUSSION
In order to fully characterize SsOGT activity, we have developed a novel method based on fluorescent derivatives of the inhibitor O 6 -BG, which are currently used to follow derivatives of hAGT, called SNAP™, used as protein tag (16, 22, 23) . We report here for the first time that such inhibitors are convenient analytical tools to assay AGT activity. The method, which can be applied to all AGTs sensitive to benzyl-guanine inhibitions, including the human protein, allows the determination of kinetics parameters for the covalent modification reaction as well as determination of the protein affinity for different substrates, is simple and reliable, highly sensitive, specific and quantitative, and allows analysis under both native and denaturing conditions.
In hAGT, the benzyl group of the O 6 -BG interacts with the P140 residue, which facilitates the correct orientation of the inhibitor in the active site (4); AGTs lacking this residue are resistant to the inhibitor. Interestingly, despite the absence of the corresponding proline residue, SsOGT was significantly inhibited by O 6 -BG derivatives, suggesting that other interactions stabilize the inhibitor in the active site pocket.
The careful biochemical characterization of SsOGT showed that, despite its thermophilic character and its high thermal stability, it also shows considerable activity at low temperature; in addition, it is active under a wide range of reaction conditions.
We have shown that our assay can be used, in combination with mutational analysis, to study the biochemical and kinetic properties of mutants impaired in DNA binding. We showed that both the R102 residue and the HTH domain are involved in DNA binding of SsOGT, and a multiple mutant completely defective for DNA binding can still be labeled efficiently by SNAPVista Green™.
Methylating agents are among the most commonly occurring mutagens in nature. Thermophilic organisms may be exposed to these agents, as by-products of biomass decay, as well as to alkylation damage generated by endogenous methylating agents, such as Sadenosylmethionine and N-nitroso-compounds, which may be highly reactive at high temperature. We reported previously that treatment of S. solfataricus cultures with high doses of MMS induces coordinate degradation of the complex formed by two proteins playing key roles in DNA damage response, namely reverse gyrase and the translesion polymerase PolY; this occurs in turn in concomitance with DNA fragmentation and cell death (8, 25) . We suggested that this apoptotic-like phenomenon might act, in the presence of irreparable DNA damage, to specifically eliminate proteins involved in lesion repair/tolerance. We now report that SsOGT is also degraded in response to MMS treatment, which might be part of the same phenomenon. However, several lines of evidence suggest that this is not the case, rather SsOGT is degraded by a different pathway. Indeed, in contrast to reverse gyrase/PolY, SsOGT is degraded even after treatment with low, not lethal MMS concentrations, although the protein level is inversely related to MMS doses. In addition, degradation requires alkylation of SsOGT and some pathway activated in vivo in response to alkylation damage. Indeed, alkylated SsOGT, either endogenous or recombinant, is degraded by some factor(s) in extracts from MMS-treated, but not control cells; the same result is not obtained by direct addition of the alkylating agent or methylated DNA to extracts from untreated cells. In similar experiments, endogenous or recombinant reverse gyrase was also degraded by incubation in vitro with extracts from MMStreated cells, but in that case direct alkylation of the protein was not required (8; A.V., unpublished results).
Alkylated AGT undergoes rapid degradation in human and yeast cells (26, 27) , thus our results suggest once more a striking evolutionary conservation, from archaea to higher eukaryotes, of an important pathway dealing with the maintenance of the genetic information, as repeatedly reported for all DNA metabolic processes (28) .
Degradation of human AGT is triggered by a conformational modification caused by the addition of the alkyl group, leading to recognition by ubiquitin ligases and channeling to the proteasome pathway. All archaea contain 20S core proteasome particles (30) , suggesting that SsOGT might be degraded by this pathway. In addition, most archaea also encode ubiquitinlike proteins called UBl and SAMP (small archaeal modifier proteins; 31, 32): Recently, SAMPs were found to be covalently linked to proteins, suggesting that they might function like ubiquitin in eukaryotes in degradation pathways. However, no such evidence is available so far; moreover, we didn't find evidence of posttranslational modifications of SsOGT before degradation; thus, either the alkylated protein is targeted to degradation without further modification, or degradation follows ubiquitinlike modification very rapidly. Further studies are underway to unravel the mechanism and factors involved in degradation of OGT in Archaea. 
